Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act
This article was originally published in The Tan Sheet
Executive Summary
Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman